Product NDC: | 60505-3438 |
Proprietary Name: | Selegiline Hydrochloride |
Non Proprietary Name: | Selegiline Hydrochloride |
Active Ingredient(s): | 5 mg/1 & nbsp; Selegiline Hydrochloride |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 60505-3438 |
Labeler Name: | Apotex Corp. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA074871 |
Marketing Category: | ANDA |
Start Marketing Date: | 19970706 |
Package NDC: | 60505-3438-8 |
Package Description: | 500 TABLET in 1 BOTTLE (60505-3438-8) |
NDC Code | 60505-3438-8 |
Proprietary Name | Selegiline Hydrochloride |
Package Description | 500 TABLET in 1 BOTTLE (60505-3438-8) |
Product NDC | 60505-3438 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Selegiline Hydrochloride |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 19970706 |
Marketing Category Name | ANDA |
Labeler Name | Apotex Corp. |
Substance Name | SELEGILINE HYDROCHLORIDE |
Strength Number | 5 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Monoamine Oxidase Inhibitor [EPC],Monoamine Oxidase Inhibitors [MoA],Monoamine Oxidase Type B Inhibitor [EPC],Monoamine Oxidase-B Inhibitors [MoA] |